S. Oh

发表

Arachidonic acid promotes skin wound healing through induction of human MSC migration by MT3-MMP-mediated fibronectin degradation

H. Lee, S.-J. Lee, Y. Jung, 2015, Cell Death and Disease.

Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

M. Roh, H. Kwon, Sooyeon Oh, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

ESICM LIVES 2016: part two

A. M. Cavalheiro, H. S. King, M. M. Moraes, 2016, Intensive Care Medicine Experimental.

Vibrio vulnificus VvhA induces NF-κB-dependent mitochondrial cell death via lipid raft-mediated ROS production in intestinal epithelial cells

E. J. Song, S.-J. Lee, Y. Jung, 2015, Cell Death and Disease.

Comparision of surgical outcomes of intraocular lens refixation and intraocular lens exchange with perfluorocarbon liquid and fibrin glue-assisted sutureless scleral fixation

S. Oh, S. J. Lee, J. M. Park, 2015, Eye.

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma

Y. S. Lee, N. Schmitz, F. d'Amore, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.

W. Kang, H. J. Kim, H. Lim, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Vibrio vulnificus VvpE inhibits mucin 2 expression by hypermethylation via lipid raft-mediated ROS signaling in intestinal epithelial cells

K. Jang, S.-J. Lee, Y. Jung, 2015, Cell Death and Disease.

New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survival

C. Jung, S. Oh, W. Kang, 2007, Bone Marrow Transplantation.

438 THE CLINICAL SIGNIFICANCE OF SERUM AND URINE CYTOKINE IN PATIENTS WITH ACUTE UNCOMPLICATED PYELONEPHRITIS

W. Chung, T. Kim, S. Myung, 2009 .

High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases

J. Lee, C. Jung, H. Kwon, 2006, Bone Marrow Transplantation.

A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer.

Y. Bang, Y. Kim, J. Kim, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

1339PDPHASE II TRIAL OF EPIDERMAL GROWTH FACTOR OINTMENT FOR PATIENTS WITH ERLOTINIB-RELATED SKIN EFFECTS.

I. Hwang, Hyo-jin Kim, H. Kim, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of FOXP3 expression in canine mammary gland tumours.

D. Yoo, I. Hwang, I. K. Hwang, 2014, Veterinary and comparative oncology.

When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?

Y. Ko, J. Huh, C. Suh, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis.

T. Yoshino, S. Nakamura, R. Suzuki, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Comprehensive analysis of Excision repair complementation group 1, Glutathione S-transferase, Thymidylate synthase, and Uridine diphosphate glucuronosyltransferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI.

H. Kwon, B. Seo, J. Kim, 2016, Journal of Clinical Oncology.

Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients

I. Hwang, Sharrell B Lee, S. Oh, 2011, Cancer Chemotherapy and Pharmacology.

A phase II study of oxaliplatin with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced or metastatic gastric cancer.

H. Kim, H. Kwon, S. Oh, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2

A. Chaudhry, M. Ufkin, H. Prince, 2023, Hematological Oncology.

A multicenter, randomized phase III trial comparing second-line chemotherapy (SLC) plus best supportive care (BSC) with BSC alone for pretreated advanced gastric cancer (AGC).

I. Hwang, S. Oh, W. Kang, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.